Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.78036 | 74 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.02809 | 75 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.64431 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.66274 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.10395 | 76 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.75681 | 74 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.60879 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.75754 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.71937 | 73 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.67559 | 73 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.7206 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.74772 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.58574 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.76421 | 74 |